Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blake, S. P.
Right arrow Articles by Raptopoulos, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blake, S. P.
Right arrow Articles by Raptopoulos, V.

Liver Metastases from Melanoma: Detection with Multiphasic Contrast-enhanced CT1

Simon P. Blake, FRCR, Karen Weisinger, MD, Michael B. Atkins, MD and Vassilios Raptopoulos, MD

1 From the Departments of Radiology (S.P.B., K.W., V.R.) and Medicine (M.B.A.) and the Cutaneous Oncology Program (S.P.B., M.B.A.), Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Boston, MA 02215. From the 1998 RSNA scientific assembly. Received September 11, 1998; revision requested October 15; revision received December 18; accepted April 30, 1999. Address reprint requests to V.R. (e-mail: vraptopo @caregroup.harvard.edu).



View larger version (143K):

[in a new window]
 
Figure 1a. CT images (window center, 70 HU; width, 200 HU) in a 58-year-old man with metastatic melanoma. (a) CT image obtained through the liver during the phase of peak hepatic arterial enhancement shows three enhanced lesions (arrows). The lesions were not present on previous images and are therefore considered to be malignant. (b) CT image obtained at the same level as a during the phase of peak portal venous enhancement shows that the three lesions are less conspicuous but are still visible.

 


View larger version (159K):

[in a new window]
 
Figure 1b. CT images (window center, 70 HU; width, 200 HU) in a 58-year-old man with metastatic melanoma. (a) CT image obtained through the liver during the phase of peak hepatic arterial enhancement shows three enhanced lesions (arrows). The lesions were not present on previous images and are therefore considered to be malignant. (b) CT image obtained at the same level as a during the phase of peak portal venous enhancement shows that the three lesions are less conspicuous but are still visible.

 


View larger version (118K):

[in a new window]
 
Figure 2a. CT images (window center, 70 HU; width, 200 HU) in a 51-year-old man with widely metastatic malignant melanoma. (a, b) CT images were obtained through the level of the hepatic veins during the phases of (a) peak hepatic arterial and (b) peak portal venous enhancement. The true extent of disease is best appreciated in b, as indicated by the presence of multiple hypoattenuating nodules in the liver. (c, d) CT images were obtained just above the level of the porta hepatis during the phases of (c) peak hepatic arterial and (d) peak portal venous enhancement. Lesions are better demonstrated in d. Multiple splenic lesions (arrows) also are visible. This patient had multiple other sites of disease throughout the chest, abdomen, pelvis, and skeleton.

 


View larger version (120K):

[in a new window]
 
Figure 2b. CT images (window center, 70 HU; width, 200 HU) in a 51-year-old man with widely metastatic malignant melanoma. (a, b) CT images were obtained through the level of the hepatic veins during the phases of (a) peak hepatic arterial and (b) peak portal venous enhancement. The true extent of disease is best appreciated in b, as indicated by the presence of multiple hypoattenuating nodules in the liver. (c, d) CT images were obtained just above the level of the porta hepatis during the phases of (c) peak hepatic arterial and (d) peak portal venous enhancement. Lesions are better demonstrated in d. Multiple splenic lesions (arrows) also are visible. This patient had multiple other sites of disease throughout the chest, abdomen, pelvis, and skeleton.

 


View larger version (135K):

[in a new window]
 
Figure 2c. CT images (window center, 70 HU; width, 200 HU) in a 51-year-old man with widely metastatic malignant melanoma. (a, b) CT images were obtained through the level of the hepatic veins during the phases of (a) peak hepatic arterial and (b) peak portal venous enhancement. The true extent of disease is best appreciated in b, as indicated by the presence of multiple hypoattenuating nodules in the liver. (c, d) CT images were obtained just above the level of the porta hepatis during the phases of (c) peak hepatic arterial and (d) peak portal venous enhancement. Lesions are better demonstrated in d. Multiple splenic lesions (arrows) also are visible. This patient had multiple other sites of disease throughout the chest, abdomen, pelvis, and skeleton.

 


View larger version (135K):

[in a new window]
 
Figure 2d. CT images (window center, 70 HU; width, 200 HU) in a 51-year-old man with widely metastatic malignant melanoma. (a, b) CT images were obtained through the level of the hepatic veins during the phases of (a) peak hepatic arterial and (b) peak portal venous enhancement. The true extent of disease is best appreciated in b, as indicated by the presence of multiple hypoattenuating nodules in the liver. (c, d) CT images were obtained just above the level of the porta hepatis during the phases of (c) peak hepatic arterial and (d) peak portal venous enhancement. Lesions are better demonstrated in d. Multiple splenic lesions (arrows) also are visible. This patient had multiple other sites of disease throughout the chest, abdomen, pelvis, and skeleton.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1999 by the Radiological Society of North America.